Brief: Lava Therapeutics To Present Updated Lava-051 Clinical Data At Meeting
27/04/2022 15:05
April 27 (Reuters) - LAVA Therapeutics NV LVTX.O :
* LAVA THERAPEUTICS TO PRESENT UPDATED LAVA-051 CLINICAL
DATA AT
THE 2022 AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) ANNUAL
MEETING
Source text for Eikon: ID:nGNXcfqCqT
Further company coverage: LVTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on LAVA Therapeutics NV
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 07:29 PM
Brief: Xoma Royalty Announces Closing Of Transactions To Acquire Lava Therapeutics N.V.
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM